It is hard to believe, but prior to 1993, all clinical trials at the National Institute of Health (NIH) were conducted only on white men. That meant diseases that predominantly affect women, like breast cancer and ovarian cancer, or those that disproportionately affect communities of color, such as sickle cell anemia, were not being researched properly.

Louise secured the first $500 million in federal funds to research breast cancer at NIH. She passed the NIH Revitalization Act of 1993, which created the Office of Research on Women’s Health, and required the NIH to include women and communities of color in all human subject research.

Scientists at NIH continue to make breakthroughs in genetics and cell biology that pave the way for innovative methods of prevention, detection, and treatments. That’s why Louise is strongly opposed to proposed cuts to NIH funding, and is advocating for expansion of health research.

Add Your Name

Join Louise